Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript - Thomson StreetEvents

Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript

Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript - Thomson StreetEvents
Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript
Published Sep 24, 2025
7 pages (3646 words) — Published Sep 24, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of PVLA.OQ corporate analyst meeting

  
Brief Excerpt:

...Operator Good day, Palvella conference call to discuss expansion of QTORIN Rapamycin Pipeline to include clinically significant Angiokeratomas. You may begin. I would now like to hand the call over to Bohan Wei. Bohan Wei ...

  
Report Type:

Transcript

Source:
Company:
Palvella Therapeutics Inc
Ticker
PVLA.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Palvella Therapeutics Inc To Discuss Topline Results from the Phase 2 TOIVA study Transcript – 2025-12-15 – US$ 54.00 – Edited Transcript of PVLA.OQ corporate analyst meeting</ 15-Dec-25 1:30pm GMT

Palvella Therapeutics Inc Q3 2025 Earnings Call Transcript – 2025-11-11 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 11-Nov-25 1:30pm GMT

Palvella Therapeutics Inc To Discuss New Product Candidate QTORIN Transcript – 2025-11-05 – US$ 54.00 – Edited Transcript of PVLA.OQ corporate analyst meeting</ 5-Nov-25 1:30pm GMT

Palvella Therapeutics Inc Q2 2025 Earnings Call Transcript – 2025-08-14 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 14-Aug-25 12:30pm GMT

Palvella Therapeutics Inc Annual Shareholders Meeting Transcript – 2025-06-10 – US$ 54.00 – Edited Transcript of PVLA.OQ shareholder or annual meeting 10-Jun-25 3:00pm GMT

Palvella Therapeutics Inc Q1 2025 Earnings Call Transcript – 2025-05-15 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 15-May-25 12:30pm GMT

Palvella Therapeutics Inc Q4 2024 Earnings Call Transcript – 2025-03-31 – US$ 54.00 – Edited Transcript of PVLA.OQ earnings conference call or presentation 31-Mar-25 12:30pm GMT

Palvella Therapeutics Inc at TD Cowen Healthcare Conference Transcript – 2025-03-04 – US$ 54.00 – Edited Transcript of PVLA.OQ presentation 4-Mar-25 7:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript" Sep 24, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Palvella-Therapeutics-Inc-To-Discuss-Expansion-of-QTORIN-Rapamycin-Pipeline-T16518424>
  
APA:
Thomson StreetEvents. (2025). Palvella Therapeutics Inc To Discuss Expansion of QTORIN Rapamycin Pipeline Transcript Sep 24, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Palvella-Therapeutics-Inc-To-Discuss-Expansion-of-QTORIN-Rapamycin-Pipeline-T16518424>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.